Home
HelpTest Code NGPLSM OncoPlus, Universal Cancer Mutation Analysis Panel (NGS), (Bone Marrow)
Specimen and Container/Tube
Bone Marrow
Rejection Criteria
Inappropriate anticoagulant and >72 hours
Turnaround Time
Not Available
Test Includes
Large-scale cancer analysis (1200 genes) with clinical
reporting
of mutations/anomalies in 155 cancer-related genes. Detects
copy
number variations for 136 genes and gene fusions in ALK, RET, and ROS1.
Includes microsatellite instability (MSI)
assessment.
Specimen Type
Bone Marrow
Preferred Volume
3 mL
Fee Code
376540-30081450
Offsite Collection Instructions
Send within 24 hours or Refrigerate/ send within 72 hours
Test Usage
Comprehensive assay for cancer genomic of solid tumor and
hematological malignancy specimens to determine appropriate
therapies. It also can be useful for diagnosis, prognosis,
clinical
trials selection and for translational research.
UCMC Collection Instructions
Send within 24 hours or Refrigerate/ send within 72 hours
Test Limitations
Will not detect mutations below the analytical sensitivity
of
the assay (10% variant allelic frequency). For detection of
FGFR1/2/3 and NTRK1/2/3 fusions, please order separate RNA Gene Fusion Panel.
STAT Turnaround Time
Not Available
Container/Tube
Lavender top
Specimen Minimum Volume
3 mL
Special Instructions
Send within 72 hours
Day(s) Performed
Monday – Friday, 8:00 AM – 4:30 PM
STAT DAY(S) AND TIME(S) PERFORMED
No
CPT
81450
Method Name
Next Generation Sequencing
Reference Values
Interpretative report
Reject Due To
Inappropriate anticoagulant and >72 hours
Pediatric Volume
3 mL
Clinical Indications
Comprehensive assay for cancer genomic of solid tumor and
hematological malignancy specimens to determine appropriate
therapies. It also can be useful for diagnosis, prognosis,
clinical
trials selection and for translational research.
Transport Instructions
Send within 24 hours or Refrigerate/ send within 72 hours
Test Components
Large-scale cancer analysis (1200 genes) with clinical
reporting
of mutations/anomalies in 155 cancer-related genes. Detects
copy
number variations for 136 genes and gene fusions in ALK, RET, and ROS1.
Includes microsatellite instability (MSI)
assessment.
Methodology
Next Generation Sequencing